ASX Share rice
Mon 17 May 2021 - 11:13:am (Sydney)

ATS Share Price

AUSTRALIS OIL & GAS LIMITEDATSEnergy

ATS Company Information

Name:

Australis Oil & Gas Limited

Sector:

Energy

Industry:

Oil & Gas E&P

GIC Industry:

Oil, Gas & Consumable Fuels

GIC Sub Industry:

Oil & Gas Exploration & Production

Address:

Allendale Square Perth WA Australia 6000

Phone:

61 8 9220 8700

CEO, MD & Director:

Mr. Ian Lincoln Lusted B.Sc (Hons.), MBA

Fin. Director, CFO & Director:

Mr. Graham Rochford Dowland

VP of Operations:

Mr. David Greene

Chief Corp. Officer:

Mr. Darren Wade Wasylucha

VP of Corp. & Bus. Devel.:

Mr. Malcolm Bult

VP of Fin. & Company Sec.:

Ms. Julie Foster

Company Overview:

Australis Oil & Gas Limited engages in the oil and gas exploration, development, and production activities. The company operates through Oil & Gas Production, Exploration, and Other segments. The company holds 100% interest in the Tuscaloosa Marine Shale covering an area of 107,500 net acres located in Louisiana and Mississippi, the United States. It also has a 100% interest in the Batalha and Pombal concessions, which cover an area of approximately 620,000 acres located onshore in the Lusitanian Basin, Portugal. Australis Oil & Gas Limited was founded in 2015 and is headquartered in Perth, Australia.

ATS Share Price Information

Shares Issued:

1.20B

Market Capitalisation:

$56.30M

Revenue (TTM):

$25.40M

Revenue Per Share (TTM):

$0.03

Earnings per Share:

$0.006

Operating Margin (TTM):

$-4.82

Return On Assets (TTM):

$-0.48

Return On Equity (TTM):

$-1.04

Quarterly Revenue Growth (YOY):

-0.486

Gross Profit(TTM):

$12.65M

Diluted Earnings Per Share (TTM):

$-0.164

QuarterlyEarnings Growth(YOY):

-0.735

ATS CashFlow Statement

CashFlow Date:

2020-12-31

Investments:

$-4,690,989.35

Change To Liabilities:

$-2,042,000

Total Cashflow From Investing Activities:

$-3,613,000

Net Borrowings:

$-12,304,000

Net Income:

$-125,208,000

Total Cash From Operating Activities:

$6.62M

Depreciation:

$130.19M

Other Cashflow From Investing Activities:

$104K

Change To Inventory:

$-278,000

Change To Account Receivables:

$2.27M

Sale Purchase Of Stock:

$-44,144.38

Capital Expenditures:

$3.72M

ATS Income Statement

Income Date:

2020-12-31

Income Before Tax:

$-162,565,567.39

Net Income:

$-162,565,567.39

Gross Profit:

$12.82M

Operating Income:

$-165,227,213.71

Interest Expense:

$3.81M

Total Revenue:

$27.81M

Cost Of Revenue:

$14.99M

ATS Balance Sheet

Balance Sheet Date:

2020-12-31

Total Liabilities:

$38.34M

Total Stockholder Equity:

$76.21M

Other Current Liabilities:

$0.97M

Total Assets:

$114.55M

Common Stock:

$176.11M

Retained Earnings:

$-127,932,000

Other Liabilities:

$2.66M

Other Assets:

$834K

Cash:

$6.09M

Total Current Liabilities:

$10.37M

Property - Plant & Equipment:

$78.96M

Net Tangible Assets:

$58.70M

Total Current Assets:

$8.44M

Long-Term Debt:

$20.66M

Net Receivables:

$3.01M

Short-Term Investments:

$103.60M

Inventory:

$736K

Accounts Payable:

$4.66M

Short-Term Investments:

$103.60

Non Current Liabilities Total:

$24.87M

ATS Share Price History

ATS News

12 Mar, 2021
Australis Capital Inc. (OTCQB: AUSAF) agreed to buy cannabis company Green Therapeutics LLC in a deal worth between CA$8 million ($6.4 million) and CA$10 million. The purchase would give the Las Vegas-based company ownership of Green Therapeutics portfolio, which includes GT Flowers, TsunamiTM and ProvisionsTM. The Deal Details The deal also settles a legal dispute between the two companies, which both parties agreed to do later this month in tandem with the initial closing. Australis will pay holders of Green Therapeutics membership interest between CA$8 million and $100 million for 100% of the interest of the entire company including a subsidiary. Out of the total amount, CA$7.5 million will be paid via the issuance of units of the company’s subsidiary, GT Acquisition, with a price of CA$0.20 per buyer unit. Each buyer unit will enable the holder to obtain one common share of the company. Some CA$500,000 as indemnity holdback will be payable 18 months after the initial closing, while up to $2 million will be payable in two parts — on the first and second anniversary of initial closing (and only if Green Therapeutics co-founder Dr. Duke Fu is still employed at the company on those dates). Once the transaction is finalized it would be immediately accretive to Australis results. Via this purchase, Australis will obtain: 8,000 square foot cultivation and manufacturing facility; Management and brand licensing agreement with an Oklahoma-based entity owned by Fu; Brand licensing agreement with an entity in Missouri owned in part by Fu The right to obtain an interest in the Oklahoma entity once the law allows it. "Entering this definitive agreement to acquire GT marks another kept promise to our shareholders," Australis CEO Terry Booth said. "With its award-winning brands, excellent operational team and assets across three states currently, combined with the leverage ALPS brings to secure novel streaming agreements, we are positioned exceptionally well to execute on our expansion strategy and develop AUSA into a top-tier MSO.” See more from BenzingaClick here for options trades from BenzingaPower REIT Buys Another Property In Colorado For Cannabis OperationsVerano Raises CA0M Selling Warrants Co-Led By Beacon Securities, Canaccord Genuity© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
18 Nov, 2020
We often see insiders buying up shares in companies that perform well over the long term. The flip side of that is...
13 Jul, 2020
Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few...